Clinical Trials · NCT00130845
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novartis
- Enrollment
- 312
- Start date
- Feb 2000
- Locations
- 1 site, United States
- Primary endpoint
- time to progression of diabetic retinopathy